A. Fujimori

发表

Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism.

M. Fukagawa, M. Koizumi, H. Komaba, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Equivalent continuous clearances EKR and stdK in incremental haemodialysis

M. Fukagawa, M. Koizumi, H. Komaba, 2012 .

Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy.

H. Naito, A. Fujimori, T. Miyazaki, 1998, Artificial organs.

Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

I. Kamae, H. Fujii, S. Goto, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Clinical Comparison of Super High-Flux HD and On-Line HDF

A. Fujimori, 2013, Blood Purification.

Calcification of the thoracic aorta determined by three-dimensional computed tomography predicts cardiovascular complications in patients undergoing hemodialysis

A. Fujimori, K. Yamamoto, M. Sakai, 2014, International Urology and Nephrology.

High plasma pentosidine is associated with prevalence of fractures in hemodialysis patients

A. Fujimori, K. Yamamoto, Kentaro Watanabe, 2013 .

2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis

T. Hasegawa, N. Hirawa, S. Nakai, 2021, Renal Replacement Therapy.

Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial

N. Yorioka, Y. Ikari, K. Iseki, 2018, JAMA.

Factors associated with calcification of the thoracic aorta determined by three-dimensional computed tomography

M. Fukagawa, A. Fujimori, Satoko Okamoto, 2010 .

Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients

H. Fujii, S. Goto, S. Nishi, 2011, American Journal of Nephrology.

Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

S. Fukumoto, M. Fukagawa, H. Nishi, 2005, Nephron Clinical Practice.

Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis

Y. Hasuike, T. Kuragano, T. Nakanishi, 2021, BMC Nephrology.

Markers in peritoneal effluent for withdrawal from peritoneal dialysis: multicenter prospective study in Japan.

J. Minakuchi, H. Kawanishi, K. Tsuchida, 2005, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Rapid Count of Microbial Cells in Dialysate

H. Matsuoka, Tomotaka Naramura, M. Saito, 2007, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism.

M. Fukagawa, Motoko Tanaka, H. Komaba, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Autopsy findings of a long-term (25 years) hemodialysis case with sarcomatoid renal cell carcinoma

H. Naito, A. Fujimori, T. Miyazaki, 1995 .

Annual dialysis data report of the 2018 JSDT Renal Data Registry: dementia, performance status, and exercise habits

T. Hasegawa, N. Hirawa, S. Nakai, 2021, Renal Replacement Therapy.

Relationship between time-dependent change in effluent interleukin-6 (IL-6) and peritoneal function

H. Naito, A. Fujimori, M. Azuma, 2002 .

Elevation of interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function.

H. Naito, A. Fujimori, T. Miyazaki, 1996, Nephron.

Effluent IL-6 is a useful marker for histological damage in the peritoneum

H. Naito, A. Fujimori, T. Miyazaki, 2001 .

Radial cortical bone mineral density in hemodialysis patients: annual changes and changes after parathyroidectomy monitored by peripheral quantitative computed tomography

H. Naito, A. Fujimori, T. Miyazaki, 1999 .

Successful treatment by continuous intraarterial infusion of vasopressin for hemorrhage from the small intestine in a dialysis patient with anaphylactoid purpura: a case report

M. Tokuyama, S. Tani, A. Fujimori, 2004 .

Twice‐Monthly Administration of a Lower Dose of Epoetin Beta Pegol Can Maintain Adequate Hemoglobin Levels in Hemodialysis Patients

A. Fujimori, M. Sakai, Shioko Okada, 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Comparison of 2‐Week Versus 4‐Week Dosing Intervals of Epoetin Beta Pegol on Erythropoiesis and Iron Metabolism in Hemodialysis Patients

A. Fujimori, M. Sakai, Shioko Okada, 2014, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Association Between Bone Mineral Density of the Distal Third of the Radius and Mortality in Patients on Hemodialysis, a Retrospective Cohort Study.

T. Kuragano, A. Fujimori, Takahide Iwasaki, 2021, Iranian Journal of Kidney Diseases.

Beta-2-microglobulin as a uremic toxin: the Japanese experience.

A. Fujimori, 2011, Contributions to nephrology.

Low-calcium dialysate improves mineral metabolism in hemodialysis patients.

M. Tokuyama, M. Fukagawa, A. Fujimori, 2007, Clinical nephrology.

Annual dialysis data report 2018, JSDT Renal Data Registry: dialysis fluid quality, hemodialysis and hemodiafiltration, peritoneal dialysis, and diabetes

T. Hasegawa, N. Hirawa, S. Nakai, 2020, Renal Replacement Therapy.